Completed PHASE2 INTERVENTIONAL 2-arm NCT00867477

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide

A Biomarker Study Comparing the Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide in Patients Who Receive Thoracic Radiotherapy

Sponsor: M.D. Anderson Cancer Center

Conditions Esophageal Cancer Gastrointestinal Disease Lung Cancer

Interventions Breathing Test Pet Scan Respiratory Symptoms Questionnaire

Updated 5 times since 2017 Last updated: Aug 27, 2014 Started: Mar 31, 2009 Primary completion: Aug 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Esophageal Cancer and Gastrointestinal Disease and is currently completed. M.D. Anderson Cancer Center leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

M.D. Anderson Cancer Center

Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States